Idiopathic pulmonary fibrosis (IPF), the most lethal form of interstitial pneumonia of unknown
cause, is associated with a specific radiological and histopathological pattern (the so-called …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease
characterized by the aberrant accumulation of fibrotic tissue in the lungs parenchyma …

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, debilitating disease of
unknown etiology and a median survival from diagnosis of 3-5 years. Despite extensive …

Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial
pneumonias. It is characterized by a chronic, progressive, fibrotic interstitial lung disease of …

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterised by chronic,
progressive scarring of the lungs and the pathological hallmark of usual interstitial …

Despite major advances in the understanding of the pathogenesis of idiopathic pulmonary
fibrosis (IPF), diagnosis and management of the condition continue to pose significant …

Despite major research efforts leading to the recent approval of pirfenidone and nintedanib,
the dismal prognosis of idiopathic pulmonary fibrosis (IPF) remains unchanged. The …

Molecular biomarkers are highly desired in idiopathic pulmonary fibrosis (IPF), where they
hold the potential to elucidate underlying disease mechanisms, accelerated drug …

Idiopathic pulmonary fibrosis (IPF), a devastating progressive interstitial lung disease (ILD)
with no known cause, is the most common and deadly of the idiopathic interstitial …

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with poor survival.
Recent studies have improved understanding of IPF and new discoveries have led to novel …